Research Topic · Peer-Reviewed

Human Immunodeficiency Virus

Human immunodeficiency virus (HIV) is a retrovirus that infects and progressively destroys cells of the immune system, particularly CD4+ T-lymphocytes, weakening the body's ability to defend against infections and certain cancers. Untreated, HIV infection can advance to acquired immunodeficiency syndrome (AIDS), the…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 42× across the literature 🔖 ISSN 2997-2108 🗓 Reviewed July 2026

Overview

Human immunodeficiency virus (HIV) is a retrovirus that infects and progressively destroys cells of the immune system, particularly CD4+ T-lymphocytes, weakening the body's ability to defend against infections and certain cancers. Untreated, HIV infection can advance to acquired immunodeficiency syndrome (AIDS), the most severe stage of disease, in which the immune system is so compromised that opportunistic infections and malignancies become life-threatening. HIV is transmitted through specific body fluids, including blood, semen, vaginal fluids, and breast milk, and during pregnancy, childbirth, or breastfeeding. Antiretroviral therapy (ART) suppresses viral replication, preserves immune function, and allows people living with HIV to achieve near-normal life expectancy, though it does not cure the infection. Key research areas include drug resistance and treatment failure, the burden of adverse drug reactions to highly active antiretroviral regimens, immune and bone health complications such as low CD4 counts and osteoporosis, opportunistic infections including fungal disease, and prevention among adolescents and other at-risk groups. The relationship between HIV and cancers, including cervical and conjunctival squamous-cell carcinoma, reflects the elevated malignancy risk in immunosuppressed individuals. Research published in this journal addresses ART experience and resistance, drug-reaction patterns, co-infections, nutritional status, and HIV-prevention education across diverse populations.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2013

Pattern of Use of Highly Active Antiretroviral Therapy Regimens and Pattern of Occurrence of Adverse Drug Reactions in an Indian Human Immunodeficiency Virus Positive Patients

Rajesh RadhakrishnanCorresponding author
Radhakrishnan Rajesh M.Pharm, Asst Professor (Senior Grade), Department of Pharmacy Practice, Manipal College of pharmaceutical Sciences, Manipal University, Manipal- 576 104, Karnataka, India.
Exact topic Clinical Research In HIV AIDS And Prevention Cited by 1 doi:10.14302/issn.2324-7339.jcrhap-12-174
2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Human Immunodeficiency Virus, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cervical Cancer (ISSN 2997-2108).

This page summarises published research for orientation; it is not medical or professional advice.